Aston Martin DB11

The DB11 has moved into oversold territory at a median of $110,000, down 8 percent over the past year—a sharp correction that reflects broader softness in the modern grand-tourer market. With only seven sales tracked in the last twelve months against a total dataset of sixteen, this is a thinly traded segment, making recent price action volatile and potentially unmoored from underlying demand.

Current market transactors are paying for low-mileage examples, with an average odometer reading of just over 8,300 miles, suggesting most DB11s entering the secondary market have seen minimal use. This points to a typical profile of ownership: enthusiasts and speculators who acquired new but did not drive, now liquidating into a market with limited appetite.

Collectibility remains modest, scoring 3 out of 10 with low overall desirability. The DB11 occupies an awkward middle ground—too recent and too common to command the collector premium of a DB5 or DB9, yet expensive enough to compete directly with newer alternatives in its original segment. Without detailed production figures available, scarcity mechanics are difficult to quantify, but the model's volume production suggests no rarity premium is warranted.

Liquidity constraints are real: zero active listings and a seven-transaction sample over twelve months indicate that buying or selling outside major auction windows requires patience and dealer intermediation. For a $110,000 car, this thinness creates friction in both directions, though it also suggests motivated sellers have already cleared out, leaving the market closer to floor than ceiling.

The three- and five-year base case projects minimal appreciation, holding at approximately $111,100—roughly flat in nominal terms. This stasis reflects the DB11's classification as a depreciating modern: no compelling collectibility narrative has emerged, and the model's trajectory suggests it will stabilize as an accessible used grand tourer rather than a hedge asset.

The high-confidence "bottomed out" signal suggests risk-reward has tilted favorably for patient buyers seeking a low-mileage, low-demand modern exotic with transaction costs now baked in. At current levels, downside appears limited, though upside appreciation remains uncertain without a material shift in collectibility sentiment.